Matches in Wikidata for { <http://www.wikidata.org/entity/Q64110569> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- Q64110569 description "artículu científicu espublizáu n'abril de 2014" @default.
- Q64110569 description "im April 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64110569 description "scientific article published on 04 April 2014" @default.
- Q64110569 description "wetenschappelijk artikel" @default.
- Q64110569 description "наукова стаття, опублікована в червні 2014" @default.
- Q64110569 name "A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s" @default.
- Q64110569 name "A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s" @default.
- Q64110569 type Item @default.
- Q64110569 label "A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s" @default.
- Q64110569 label "A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s" @default.
- Q64110569 prefLabel "A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s" @default.
- Q64110569 prefLabel "A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group s" @default.
- Q64110569 P1433 Q64110569-A4B2B01D-5E01-4D33-BD16-6382602861A0 @default.
- Q64110569 P1476 Q64110569-01A7E129-884D-4443-B02F-9FCD9D534961 @default.
- Q64110569 P2093 Q64110569-280D4E72-2DFA-442F-85A2-98E2C7DC849D @default.
- Q64110569 P2093 Q64110569-653F5CB4-D8FE-4499-BC21-D151E9342860 @default.
- Q64110569 P2093 Q64110569-66D60B49-C04D-49FC-8C38-B381262646B6 @default.
- Q64110569 P2093 Q64110569-6C6F050C-6E55-4378-9A3E-DD39BF0E5BEF @default.
- Q64110569 P2093 Q64110569-8AC1F0C6-D41C-431C-BB02-A452D23874B7 @default.
- Q64110569 P2093 Q64110569-B8A4841A-DD4E-4A4B-AF7C-4EB97666DDCA @default.
- Q64110569 P2093 Q64110569-D2D6429B-D076-41FC-B3CA-00E39B837445 @default.
- Q64110569 P2860 Q64110569-091E580A-E6CA-41F7-B7A7-928EC0DB0FD6 @default.
- Q64110569 P2860 Q64110569-1067699D-2AD4-4A62-A5BD-3DE32523B384 @default.
- Q64110569 P2860 Q64110569-1E19315F-20E3-430E-A654-A4235567A751 @default.
- Q64110569 P2860 Q64110569-247E5C7E-23B1-420A-B355-9B6F0C41F2F1 @default.
- Q64110569 P2860 Q64110569-25591ABB-7657-4C6A-B467-01DB9E194500 @default.
- Q64110569 P2860 Q64110569-41879039-5836-4D69-9738-F21634330C5F @default.
- Q64110569 P2860 Q64110569-4B6898D6-D3D2-4B92-9DC8-1711F42E9A63 @default.
- Q64110569 P2860 Q64110569-524F1986-1DCA-4BF8-8F2A-69ECC952301E @default.
- Q64110569 P2860 Q64110569-64245E34-AB12-4445-8623-B011276E85C8 @default.
- Q64110569 P2860 Q64110569-7CE2BBEA-A4C8-469F-BABD-B934F52AD2CF @default.
- Q64110569 P2860 Q64110569-83B7F05A-4204-4A26-8384-2757403F5D8E @default.
- Q64110569 P2860 Q64110569-84F5ADB4-5BBF-4F5A-B1F6-F28A262CF17D @default.
- Q64110569 P2860 Q64110569-9B0FB150-EBAB-4A31-9C9E-79ECA337E64A @default.
- Q64110569 P2860 Q64110569-AD4BCFE2-51E4-44BE-97A6-73C3139C6810 @default.
- Q64110569 P2860 Q64110569-B08F06AE-27E5-4112-9DEE-D528FAA658EC @default.
- Q64110569 P2860 Q64110569-D781E249-9DDA-4565-8692-CD6CF9B62788 @default.
- Q64110569 P2860 Q64110569-E83527D4-E460-43D9-BCB0-9E1AD4A08F4D @default.
- Q64110569 P2860 Q64110569-EA7F1861-EDF2-49F6-8CB2-AAE727623EA5 @default.
- Q64110569 P304 Q64110569-355C85B4-44AE-4281-B6AF-559E06A2E32C @default.
- Q64110569 P31 Q64110569-81607BB5-9759-47A2-AF1A-67ED8656DB72 @default.
- Q64110569 P356 Q64110569-AB2F5A8C-D759-4C6A-AB99-89F412D3F215 @default.
- Q64110569 P407 Q64110569-996969CA-4172-4CCB-9DC7-C73189BBB336 @default.
- Q64110569 P433 Q64110569-80735265-07E6-4286-B604-966E2B967BDA @default.
- Q64110569 P478 Q64110569-6B6A155D-7FB3-4201-ABD4-2EB6ACBAB802 @default.
- Q64110569 P50 Q64110569-81B43ED0-129F-4922-8AC5-120A37D437D0 @default.
- Q64110569 P577 Q64110569-85235AD4-2817-4A65-A9AD-BCA94B99A7FB @default.
- Q64110569 P698 Q64110569-207B04CB-FC3F-413F-97C6-4E95E7DA59B6 @default.
- Q64110569 P921 Q64110569-1B61D0D6-4354-4DD6-97DB-E27DD49AB0DF @default.
- Q64110569 P921 Q64110569-DD91E296-328E-426C-862A-8C1F7F27EC1D @default.
- Q64110569 P921 Q64110569-F36A3781-4442-489A-93BE-C8703C9DF7BB @default.
- Q64110569 P932 Q64110569-070D6339-F0A8-4BDB-9132-F2C8EFA58333 @default.
- Q64110569 P356 J.YGYNO.2014.03.571 @default.
- Q64110569 P698 24708919 @default.
- Q64110569 P1433 Q5625182 @default.
- Q64110569 P1476 "A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study" @default.
- Q64110569 P2093 "Carolyn Y Muller" @default.
- Q64110569 P2093 "David P Bender" @default.
- Q64110569 P2093 "Michael W Sill" @default.
- Q64110569 P2093 "Robert L DeBernardo" @default.
- Q64110569 P2093 "Ronald D Alvarez" @default.
- Q64110569 P2093 "Susan A Davidson" @default.
- Q64110569 P2093 "Warner K Huh" @default.
- Q64110569 P2860 Q33552702 @default.
- Q64110569 P2860 Q36174230 @default.
- Q64110569 P2860 Q36403093 @default.
- Q64110569 P2860 Q36470056 @default.
- Q64110569 P2860 Q36631249 @default.
- Q64110569 P2860 Q36687666 @default.
- Q64110569 P2860 Q37053564 @default.
- Q64110569 P2860 Q37494817 @default.
- Q64110569 P2860 Q37851520 @default.
- Q64110569 P2860 Q40106661 @default.
- Q64110569 P2860 Q40240958 @default.
- Q64110569 P2860 Q40354978 @default.
- Q64110569 P2860 Q40370693 @default.
- Q64110569 P2860 Q42804701 @default.
- Q64110569 P2860 Q44405564 @default.
- Q64110569 P2860 Q45885989 @default.
- Q64110569 P2860 Q47751137 @default.
- Q64110569 P2860 Q77554900 @default.
- Q64110569 P304 "433-438" @default.
- Q64110569 P31 Q13442814 @default.
- Q64110569 P356 "10.1016/J.YGYNO.2014.03.571" @default.
- Q64110569 P407 Q1860 @default.
- Q64110569 P433 "3" @default.
- Q64110569 P478 "133" @default.
- Q64110569 P50 Q56332429 @default.
- Q64110569 P577 "2014-04-04T00:00:00Z" @default.
- Q64110569 P698 "24708919" @default.
- Q64110569 P921 Q1233836 @default.
- Q64110569 P921 Q42824440 @default.
- Q64110569 P921 Q5625186 @default.
- Q64110569 P932 "4057915" @default.